Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

57%

4 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

2(33.3%)

N/A

2(33.3%)

Phase 3

2(33.3%)

6Total

Phase 4(2)

N/A(2)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05346978Not ApplicableCompleted

Nasturtium (Tropaeolum Majus L) Intake and Biochemical Parameters in Pre-diabetic Subjects in Bogota Colombia

Role: lead

NCT04527211Phase 3Unknown

Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel

Role: lead

NCT03650543Phase 4Completed

Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication

Role: lead

NCT02156414Completed

Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate Cancer

Role: lead

NCT00104533Phase 3Completed

Effectiveness of Magnetic Therapy on Pain Intensity

Role: lead

NCT00106717Not ApplicableCompleted

Effectiveness of Narrative Medicine on Pain Intensity and Quality of Life

Role: lead

NCT00609375Phase 4Completed

Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen

Role: lead

All 7 trials loaded